It’s time for another dive into the biggest pre-market stock movers as we check out the shares worth watching on Tuesday!
Moving shares are company mergers, bankruptcy news, a new contract, and more.
Let’s get into that news below!
Pre-Market Stock Movers: 10 Top Gainers
- Tivic Health Systems (NASDAQ:TIVC) stock is rocketing more than 135% alongside heavy pre-market trading.
- Shineco (NASDAQ:SISI) shares are soaring over 46% as they also see strong early morning trading.
- Noco-noco (NASDAQ:NCNC) stock is surging 42% following its .
- Crown ElectroKinetics (NASDAQ:CRKN) shares are gaining 19% without any news to report this morning.
- Sunshine Biopharma (NASDAQ:SBFM) stock is rising more than 18% despite a lack of news this morning.
- iCoreConnect (NASDAQ:ICCT) shares are increasing over 18% after yesterday.
- Caravelle International (NASDAQ:CACO) stock is climbing more than 17% following an .
- Bright Scholar Education (NYSE:BEDU) shares are jumping over 14% on Tuesday morning.
- Castellum (NYSEMKT:CTM) stock is getting a more than 14% boost after announcing .
- PDD Holdings (NASDAQ:PDD) stock is up close to 14% .
10 Top Losers
- Companhia Brasileira (NYSE:CBD) stock is crashing over 66% without any recent news worth mentioning.
- AgileThought (NASDAQ:AGIL) shares are diving more than 19% after filing for .
- BioNexus Gene Lab (NASDAQ:BGLC) stock is tumbling nearly 14% on no apparent news this morning.
- Orgenesis (NASDAQ:ORGS) shares are taking an over 12% beating on Tuesday morning.
- VinFast Auto (NASDAQ:VFS) stock is dropping more than 11% .
- Vahanna Tech Edge (NASDAQ:VHNA) shares are decreasing over 10% after getting approval for .
- TC BioPharm (NASDAQ:TCBP) stock is sliding more than 8% .
- Enveric Biosciences (NASDAQ:ENVB) shares are slipping over 8% .
- T2 Biosystems (NASDAQ:TTOO) stock is dipping more than 8% as it continues negative movement from yesterday.
- Genius (NYSEMKT:GNS) shares close out our pre-market stock movers down over 8% following the .
On the date of publication, William White did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the InvestorPlace.com Publishing Guidelines.
